• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care
Prostate Cancer : Episode 11

Episode 11 - Personalized Medicine in CRPC

Video

During this segment, the panelists explore the use of personalized medicine in castration-resistant prostate cancer.

Jeffrey D. Dunn, PharmD, MBA, and Raoul S. Concepcion, MD, explain that clinicians hope to have better data available in the future to provide definitive answers about treatment options for specific patient populations.

Dr Concepcion explains the variables that are being reviewed to help clinicians make wiser treatment decisions for their patients.

However, E. David Crawford, MD, reminds the panelists why achieving this goal will not be easy.


Related Videos
Tiffany Meng, PharmD, oncology pharmacist with UCSF Health
Rachel Rohaidy, MD
Tiffany Meng, PharmD, oncology pharmacist, UCSF Health
Screenshot of an interview with Shaun McKenzie, MD
Jeffrey Stark, MD, vice president and head of medical immunology at UCB.
Sabarish Ayyappan, MD
Dr Maria DeYoreo
Screenshot of an interview with Shaun McKenzie, MD
Jade E. Jones, MD
Screenshot of an interview with Rohan Garje, MD
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.